330 related articles for article (PubMed ID: 34561952)
1. ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.
Memon B; Abdelalim EM
Acta Physiol (Oxf); 2021 Dec; 233(4):e13733. PubMed ID: 34561952
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic
Fignani D; Licata G; Brusco N; Nigi L; Grieco GE; Marselli L; Overbergh L; Gysemans C; Colli ML; Marchetti P; Mathieu C; Eizirik DL; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():596898. PubMed ID: 33281748
[TBL] [Abstract][Full Text] [Related]
3. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
Rangu R; Wander PL; Barrow BM; Zraika S
J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells.
Coate KC; Cha J; Shrestha S; Wang W; Gonçalves LM; Almaça J; Kapp ME; Fasolino M; Morgan A; Dai C; Saunders DC; Bottino R; Aramandla R; Jenkins R; Stein R; Kaestner KH; Vahedi G; ; Brissova M; Powers AC
Cell Metab; 2020 Dec; 32(6):1028-1040.e4. PubMed ID: 33207245
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.
Wu CT; Lidsky PV; Xiao Y; Lee IT; Cheng R; Nakayama T; Jiang S; Demeter J; Bevacqua RJ; Chang CA; Whitener RL; Stalder AK; Zhu B; Chen H; Goltsev Y; Tzankov A; Nayak JV; Nolan GP; Matter MS; Andino R; Jackson PK
Cell Metab; 2021 Aug; 33(8):1565-1576.e5. PubMed ID: 34081912
[TBL] [Abstract][Full Text] [Related]
6. Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic β cells: to be or not to be!
El-Huneidi W; Hamad M; Taneera J
Islets; 2021 Sep; 13(5-6):106-114. PubMed ID: 34304698
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors.
Fignani D; Pedace E; Licata G; Grieco GE; Aiello E; de Luca C; Marselli L; Marchetti P; Sebastiani G; Dotta F
Diabetes Metab Res Rev; 2023 Nov; 39(8):e3696. PubMed ID: 37466955
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
9. FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection.
Meng H; Liao Z; Ji Y; Wang D; Han Y; Huang C; Hu X; Chen J; Zhang H; Li Z; Wang C; Sun H; Sun J; Chen L; Yin J; Zhao J; Xu T; Liu H
Signal Transduct Target Ther; 2024 Apr; 9(1):104. PubMed ID: 38654010
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 and pancreas: a potential pathological interaction?
Geravandi S; Mahmoudi-Aznaveh A; Azizi Z; Maedler K; Ardestani A
Trends Endocrinol Metab; 2021 Nov; 32(11):842-845. PubMed ID: 34373155
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes regulate expression of the SARS-CoV-2 cell entry factor ACE2 in the pancreas of T2DM patients.
Zhang P; Zheng CB; Liu XY; Zhang X; Huang L; Zeng X
Diabet Med; 2023 Oct; 40(10):e15106. PubMed ID: 37014274
[TBL] [Abstract][Full Text] [Related]
12. Limited extent and consequences of pancreatic SARS-CoV-2 infection.
van der Heide V; Jangra S; Cohen P; Rathnasinghe R; Aslam S; Aydillo T; Geanon D; Handler D; Kelley G; Lee B; Rahman A; Dawson T; Qi J; D'Souza D; Kim-Schulze S; Panzer JK; Caicedo A; Kusmartseva I; Posgai AL; Atkinson MA; Albrecht RA; García-Sastre A; Rosenberg BR; Schotsaert M; Homann D
Cell Rep; 2022 Mar; 38(11):110508. PubMed ID: 35247306
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes.
Qadir MMF; Bhondeley M; Beatty W; Gaupp DD; Doyle-Meyers LA; Fischer T; Bandyopadhyay I; Blair RV; Bohm R; Rappaport J; Lazartigues E; Heide RSV; Kolls JK; Qin X; Mauvais-Jarvis F
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34241597
[TBL] [Abstract][Full Text] [Related]
14. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
16. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
Scialo F; Daniele A; Amato F; Pastore L; Matera MG; Cazzola M; Castaldo G; Bianco A
Lung; 2020 Dec; 198(6):867-877. PubMed ID: 33170317
[TBL] [Abstract][Full Text] [Related]
17. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
[TBL] [Abstract][Full Text] [Related]
18. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
Shaharuddin SH; Wang V; Santos RS; Gross A; Wang Y; Jawanda H; Zhang Y; Hasan W; Garcia G; Arumugaswami V; Sareen D
Front Cell Infect Microbiol; 2021; 11():678482. PubMed ID: 34282405
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
Chhabra KH; Xia H; Pedersen KB; Speth RC; Lazartigues E
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E874-84. PubMed ID: 23462816
[TBL] [Abstract][Full Text] [Related]
20. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
